Who is sponsoring NCT00311779?

NCT00311779 is sponsored by ParaPRO LLC.

What condition does NCT00311779 study?

NCT00311779 studies Pediculosis Capitis (Head Lice).

What drugs are being tested in NCT00311779?

Interventions: Spinosad Creme Rinse.

What is the status of NCT00311779?

NCT00311779 is currently COMPLETED.

Last reviewed 2006-07-11 · How we verify

Phase 2 Study of Efficacy and Safety of Different Strengths of Spinosad Topical Creme Rinse (0%, 0.5% or 1.0%) in Subjects 2 Years of Age or Older With Pediculosis Capitis - A Dose Ranging Study

NCT00311779 Phase 2 COMPLETED

The primary objective of the study is to determine the safety and efficacy of different strengths of Spinosad topical creme, as compared to a vehicle control, in subjects who have been infested with at least a mild case of Pediculosis capitis (head lice).

Details

Lead sponsor	ParaPRO LLC
Phase	Phase 2
Status	COMPLETED
Enrolment	120
Start date	2006-03
Completion	2006-07

Conditions

Pediculosis Capitis (Head Lice)

Interventions

Spinosad Creme Rinse

Primary outcomes

Efficacy variable: The presence/absence of live lice and/or nits at Day 7 and Day 14.
Safety Analyses: The assessment of safety will be based on frequency of adverse events and on the scalp evaluations for irritation.

Countries

United States